Pharmacokinetics of Antiretroviral Regimens Containing Tenofovir Disoproxil Fumarate and Atazanavir-Ritonavir in Adolescents and Young Adults with Human Immunodeficiency Virus Infection

The primary objective of this study was to measure atazanavir-ritonavir and tenofovir pharmacokinetics when the drugs were used in combination in young adults with human immunodeficiency virus (HIV). HIV-infected subjects ≥18 to <25 years old receiving (≥28 days) 300/100 mg atazanavir-ritonavir p...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kiser, Jennifer J., Fletcher, Courtney V., Flynn, Patricia M., Cunningham, Coleen K., Wilson, Craig M., Kapogiannis, Bill G., Major-Wilson, Hanna, Viani, Rolando M., Liu, Nancy X., Muenz, Larry R., Harris, D. Robert, Havens, Peter L.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology (ASM) 2008
Sujets:
Antiviral Agents
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2224775/
https://ncbi.nlm.nih.gov/pubmed/18025112
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00761-07
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires